Overview

Evaluation of the Effects of Duloxetine on Norepinephrine

Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate how taking duloxetine 60mg every day affects the transfer of two normal body chemicals, 3,4-dihydroxyphenylglycol (DHPG) and norepinephrine (NE), across cells in blood and cerebrospinal fluid.
Phase:
Phase 1
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Citalopram
Duloxetine Hydrochloride
Norepinephrine